Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Seamlessly bridge your LNP discovery journey from RUO to bulk GLP-tox and GMP excipient-grade material.
Explore CGMP Lipid ServicesYK-712 is an ionizable cationic lipid that has been used in the generation of lipid nanoparticles (LNPs) for the delivery of mRNA in vitro and in vivo.1 Intramuscular administration of LNPs containing YK-712 and encapsulating mRNA encoding luciferase accumulate primarily in the liver in mice, while those containing both YK-712 and an adjuvant lipid, YK-TLR-001, which contains the toll-like receptor 7/8 (TLR7/8) dual agonist AXC-715 (YK-712-TLR-LNPs), accumulate primarily in the spleen. Intramuscular administration of YK-712-TLR-LNPs encapsulating mRNA encoding ovalbumin (OVA) promotes the maturation of antigen-presenting cells (APCs), induces activation of T cells, and increases plasma levels of IFN-γ in mice. Intramuscular administration of YK-712-TLR-LNPs also reduces tumor growth and increases survival in a murine model of melanoma using OVA-expressing B16/F10 cells.
WARNING This product is not for human or veterinary use.
1. Cyclic acetal-